Please enable Javascript

Labmeeting uses lots of Javascript - basically you can't use the site without it. So please enable Javascript in your browser. If your browser does not support Javascript, we recommend Firefox.

Papers authored by Clotet B

Collect these papers and discover other ones on Labmeeting. Learn more.

Pharmacokinetics of Fosamprenavir plus Ritonavir in Human Immunodeficiency Virus Type 1-Infected Adult Subjects with Hepatic Impairment.

+ cite this

+ View Abstract

Pérez-Elías MJ, Morellon ML, Ortega E, Hernández-Quero J, Rodríguez-Torres M, Clotet B, Felizarta F, Gutiérrez F, Pineda JA, Nichols G, Lou Y, and Wire MB

Antimicrobial agents and chemotherapy 53(12):5185-96, 2009 Dec - Who cited this? | PubMed ID: 19667283 | Fulltext

Transmission of drug-resistant HIV-1 is stabilizing in Europe.

+ cite this

+ View Abstract

Vercauteren J, Wensing AM, van de Vijver DA, Albert J, Balotta C, Hamouda O, Kücherer C, Struck D, Schmit JC, Asjö B, Bruckova M, Camacho RJ, Clotet B, Coughlan S, Grossman Z, Horban A,

(show remaining authors)

The Journal of infectious diseases 200(10):1503-8, 2009 Nov 15 - Who cited this? | PubMed ID: 19835478 | Fulltext

Increased Peripheral Proinflammatory Cytokines in HIV-1-Infected Patients With Prolonged Viral Suppression Suffering From High Psychological Stress.

+ cite this

Fumaz CR, Gonzalez-Garcia M, Borras X, Ferrer MJ, Muñoz-Moreno JA, Peña R, Perez-Alvarez N, Puig J, Paredes R, Fernandez-Castro J, and Clotet B

Journal of acquired immune deficiency syndromes (1999) 52(3):427-8, 2009 Nov 1 - Who cited this? | PubMed ID: 19858924 | Fulltext

Epistasis among deleterious mutations in the HIV-1 protease.

+ cite this

+ View Abstract

Parera M, Perez-Alvarez N, Clotet B, and Martínez MA

Journal of molecular biology 392(2):243-50, 2009 Sep 18 - Who cited this? | PubMed ID: 19607838 | Fulltext

Improvement of mitochondrial toxicity in patients receiving a nucleoside reverse-transcriptase inhibitor-sparing strategy: results from the Multicenter Study with Nevirapine and Kaletra (MULTINEKA).

+ cite this

+ View Abstract

Negredo E, Miró O, Rodríguez-Santiago B, Garrabou G, Estany C, Masabeu A, Force L, Barrufet P, Cucurull J, Domingo P, Alonso-Villaverde C, Bonjoch A, Morén C, Pérez-Alvarez N, Clotet B, and MULTINEKA Study Group

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 49(6):892-900, 2009 Sep 15 - Who cited this? | PubMed ID: 19663689 | Fulltext

Rate of accumulation of thymidine analogue mutations in patients continuing to receive virologically failing regimens containing zidovudine or stavudine: implications for antiretroviral therapy programs in resource-limited settings.

+ cite this

+ View Abstract

Cozzi-Lepri A, Phillips AN, Martinez-Picado J, Monforte A, Katlama C, Eg Hansen AB, Horban A, Bruun J, Clotet B, Lundgren JD, and EuroSIDA Study Group

The Journal of infectious diseases 200(5):687-97, 2009 Sep 1 - Who cited this? | PubMed ID: 19604043 | Fulltext

Effect of the human immunodeficiency virus type 1 reverse transcriptase polymorphism leu-214 on replication capacity and drug susceptibility.

+ cite this

+ View Abstract

Puertas MC, Buzón MJ, Artese A, Alcaro S, Menendez-Arias L, Perno CF, Clotet B, Ceccherini-Silberstein F, and Martinez-Picado J

Journal of virology 83(15):7434-9, 2009 Aug - Who cited this? | PubMed ID: 19457988 | Fulltext

HIV endocytosis after dendritic cell to T cell viral transfer leads to productive virus infection.

+ cite this

+ View Abstract

Clotet-Codina I, Bosch B, Senserrich J, Fernández-Figueras MT, Peña R, Ballana E, Bofill M, Clotet B, and Esté JA

Antiviral research 83(1):94-8, 2009 Jul - Who cited this? | PubMed ID: 19501262 | Fulltext

Hyaluronic acid, transforming growth factor-beta1 and hepatic fibrosis in patients with chronic hepatitis C virus and human immunodeficiency virus co-infection.

+ cite this

+ View Abstract

Sanvisens A, Serra I, Tural C, Tor J, Ojanguren I, Barluenga E, Rey-Joly C, Clotet B, and Muga R

Journal of viral hepatitis 16(7):513-8, 2009 Jul - Who cited this? | PubMed ID: 19200132 | Fulltext

A simplification trial switching from nucleoside reverse transcriptase inhibitors to once-daily fixed-dose abacavir/lamivudine or tenofovir/emtricitabine in HIV-1-infected patients with virological suppression.

+ cite this

+ View Abstract

Martínez E, Arranz JA, Podzamczer D, Loncá M, Sanz J, Barragán P, Ribera E, Knobel H, Roca V, Gutiérrez F, Blanco JL, Mallolas J, Llibre JM, Clotet B, Dalmau D, Segura F,

(show remaining authors)

Journal of acquired immune deficiency syndromes (1999) 51(3):290-7, 2009 Jul 1 - Who cited this? | PubMed ID: 19398921 | Fulltext

The changing face of HIV/AIDS in treated patients.

+ cite this

+ View Abstract

Llibre JM, Falco V, Tural C, Negredo E, Pineda JA, Muñoz J, Ortega E, Videla S, Sirera G, Martinez E, Miralles C, Iribarren J, Galindo MJ, Domingo P, d'Arminio-Monforte A, Miro JM,

(show remaining authors)

Current HIV research 7(4):365-77, 2009 Jul - Who cited this? | PubMed ID: 19601771 | Fulltext

Lymphogranuloma venerium proctitis in the setting of HIV: a case report and differential diagnosis.

+ cite this

Heras E, Llibre JM, Sirera G, Mate JL, Boix V, Rey-Joly C, and Clotet B

AIDS patient care and STDs 23(7):493-4, 2009 Jul - Who cited this? | PubMed ID: 19534601 | Fulltext

A step ahead on the HIV collaboratory.

+ cite this

Murphy RL, Autran B, Katlama C, Brucker G, Debre P, Calvez V, Clotet B, Clumeck N, Costagliola D, Deeks SG, Dorrell L, Gatell J, Haase A, Klein M, Lazzarin A, McMichael AJ,

(show remaining authors)

Science (New York, N.Y.) 324(5932):1264-5, 2009 Jun 5 - Who cited this? | PubMed ID: 19498149 | Fulltext

Low Levels of Adherence to Antiretroviral Therapy in HIV-1-Infected Women with Menstrual Disorders.

+ cite this

+ View Abstract

Fumaz CR, Muñoz-Moreno JA, Ferrer MJ, Negredo E, Pérez-Alvarez N, Tarrats A, and Clotet B

AIDS patient care and STDs 23(6):463-8, 2009 Jun - Who cited this? | PubMed ID: 19519230 | Fulltext

A double-blind, placebo-controlled trial of maraviroc in treatment-experienced patients infected with non-R5 HIV-1.

+ cite this

+ View Abstract

Saag M, Goodrich J, Fätkenheuer G, Clotet B, Clumeck N, Sullivan J, Westby M, van der Ryst E, Mayer H, and A4001029 Study Group

The Journal of infectious diseases 199(11):1638-47, 2009 Jun 1 - Who cited this? | PubMed ID: 19432546 | Fulltext

Saquinavir exposure in HIV-infected patients with chronic viral hepatitis.

+ cite this

+ View Abstract

Moltó J, Llibre JM, Ribera E, Mínguez C, del Río JS, Pedrol E, Vallecillo G, Cedeño S, Valle M, Miranda C, Negredo E, Clotet B, and SQV-HEP Study Group

The Journal of antimicrobial chemotherapy 63(5):992-7, 2009 May - Who cited this? | PubMed ID: 19279052 | Fulltext

Pilot Pharmacokinetic Study of Human Immunodeficiency Virus-Infected Patients Receiving Tenofovir Disoproxil Fumarate (TDF): Investigation of Systemic and Intracellular Interactions between TDF and Abacavir, Lamivudine, or Lopinavir-Ritonavir.

+ cite this

+ View Abstract

Pruvost A, Negredo E, Théodoro F, Puig J, Levi M, Ayen R, Grassi J, and Clotet B

Antimicrobial agents and chemotherapy 53(5):1937-43, 2009 May - Who cited this? | PubMed ID: 19273671 | Fulltext

Efficacy and safety of switching from boosted lopinavir to boosted atazanavir in patients with virological suppression receiving a LPV/r-containing HAART: the ATAZIP study.

+ cite this

+ View Abstract

Mallolas J, Podzamczer D, Milinkovic A, Domingo P, Clotet B, Ribera E, Gutiérrez F, Knobel H, Cosin J, Ferrer E, Arranz JA, Roca V, Vidal F, Murillas J, Pich J, Pedrol E,

(show remaining authors)

Journal of acquired immune deficiency syndromes (1999) 51(1):29-36, 2009 May 1 - Who cited this? | PubMed ID: 19390327 | Fulltext

Transport of Lamivudine [(-)-{beta}-L-2',3'-Dideoxy-3'-thiacytidine] and High-Affinity Interaction of Nucleoside Reverse Transcriptase Inhibitors with Human Organic Cation Transporters 1, 2, and 3.

+ cite this

+ View Abstract

Minuesa G, Volk C, Molina-Arcas M, Gorboulev V, Erkizia I, Arndt P, Clotet B, Pastor-Anglada M, Koepsell H, and Martinez-Picado J

The Journal of pharmacology and experimental therapeutics 329(1):252-61, 2009 Apr - Who cited this? | PubMed ID: 19141712 | Fulltext

Four-year safety with polyacrylamide hydrogel to correct antiretroviral-related facial lipoatrophy.

+ cite this

+ View Abstract

Negredo E, Puig J, Aldea D, Medina M, Estany C, Pérez-Alvarez N, Rodríguez-Fumaz C, Muñoz-Moreno JA, Higueras C, Gonzalez-Mestre V, and Clotet B

AIDS research and human retroviruses 25(4):451-5, 2009 Apr - Who cited this? | PubMed ID: 19320569 | Fulltext

Accuracy of simple biochemical tests in identifying liver fibrosis in patients co-infected with human immunodeficiency virus and hepatitis C virus.

+ cite this

+ View Abstract

Tural C, Tor J, Sanvisens A, Pérez-Alvarez N, Martínez E, Ojanguren I, García-Samaniego J, Rockstroh J, Barluenga E, Muga R, Planas R, Sirera G, Rey-Joly C, and Clotet B

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 7(3):339-45, 2009 Mar - Who cited this? | PubMed ID: 19171202 | Fulltext

A randomized, open-label study of a nucleoside analogue reverse transcriptase inhibitor-sparing regimen in antiretroviral-naive HIV-infected patients.

+ cite this

Harris M, Côté H, Ochoa C, Allavena C, Negredo E, Thorne A, Cahn P, Zala C, Raffi F, Clotet B, Singer J, Montaner J, and CTN 177 Study Team

Journal of acquired immune deficiency syndromes (1999) 50(3):335-7, 2009 Mar 1 - Who cited this? | PubMed ID: 19242263 | Fulltext

Epidemiological data of different human papillomavirus genotypes in cervical specimens of HIV-1-infected women without history of cervical pathology.

+ cite this

+ View Abstract

Videla S, Darwich L, Cañadas MP, Paredes R, Tarrats A, Castella E, Llatjos M, Bofill M, Clotet B, Sirera G, and HIV-HPV Study Group

Journal of acquired immune deficiency syndromes (1999) 50(2):168-75, 2009 Feb 1 - Who cited this? | PubMed ID: 19131892 | Fulltext

Contribution of immunological and virological factors to extremely severe primary HIV type 1 infection.

+ cite this

+ View Abstract

Dalmau J, Puertas MC, Azuara M, Mariño A, Frahm N, Mothe B, Izquierdo-Useros N, Buzón MJ, Paredes R, Matas L, Allen TM, Brander C, Rodrigo C, Clotet B, and Martinez-Picado J

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 48(2):229-38, 2009 Jan 15 - Who cited this? | PubMed ID: 19093810 | Fulltext

Antigp41 antibodies fail to block early events of virological synapses but inhibit HIV spread between T cells.

+ cite this

+ View Abstract

Massanella M, Puigdomènech I, Cabrera C, Fernandez-Figueras MT, Aucher A, Gaibelet G, Hudrisier D, García E, Bofill M, Clotet B, and Blanco J

AIDS (London, England) 23(2):183-8, 2009 Jan 14 - Who cited this? | PubMed ID: 19098487 | Fulltext

Evaluation of the anti-HIV activity of natalizumab, an antibody against integrin alpha4.

+ cite this

+ View Abstract

Pauls E, Ballana E, Moncunill G, Bofill M, Clotet B, Ramo-Tello C, and Esté JA

AIDS (London, England) 23(2):266-8, 2009 Jan 14 - Who cited this? | PubMed ID: 19112691 | Fulltext

Prescribing and using self-injectable antiretrovirals: How concordant are physician and patient perspectives?.

+ cite this

+ View Abstract

Horne R, Kovacs C, Katlama C, Clotet B, Fumaz CR, Youle M, Kulasegaram R, Fisher M, Cohen C, Slim J, Shalit P, Cooper V, and Tsoukas C

AIDS research and therapy 6:2, 2009 - Who cited this? | PubMed ID: 19196474 | Fulltext

Risk factors for loss of virological suppression in patients receiving lopinavir/ritonavir monotherapy for maintenance of HIV suppression.

+ cite this

+ View Abstract

Pulido F, Pérez-Valero I, Delgado R, Arranz A, Pasquau J, Portilla J, Rubio R, González-García J, Miralles P, Pérez-Elías MJ, Ocampo A, Hernando A, Estrada V, Clotet B, Podzamczer D, and Arribas JR

Antiviral therapy 14(2):195-201, 2009 - Who cited this? | PubMed ID: 19430094 | Fulltext

Neuropsychiatric symptoms associated with efavirenz: prevalence, correlates, and management. A neurobehavioral review.

+ cite this

+ View Abstract

Muñoz-Moreno JA, Fumaz CR, Ferrer MJ, González-García M, Moltó J, Negredo E, and Clotet B

AIDS reviews 11(2):103-9, 2009 - Who cited this? | PubMed ID: 19529750 | Fulltext

Unboosted Atazanavir Plus Co-formulated Lamivudine/Abacavir as a Ritonavir-Sparing Simplification Strategy in Routine Clinical Practice.

+ cite this

+ View Abstract

Santos JR, Moltó J, Llibre JM, Pérez N, Capitán, Miranda C, and Clotet B

HIV clinical trials 10(3):129-34, 2009 - Who cited this? | PubMed ID: 19632951 | Fulltext

Short-Term Effect of Ritonavir-Boosted Atazanavir in Hepatitis B and/or C Co-infected, Treatment-Experienced HIV Patients.

+ cite this

+ View Abstract

Pérez-Elías MJ, Gatell JM, Flores J, Santos J, Vera-Médez F, Clotet B, Moreno A, Pérez-Molina JA, Vendrell B, and Serrano O

HIV clinical trials 10(4):269-75, 2009 - Who cited this? | PubMed ID: 19723614 | Fulltext

On the steps of cell-to-cell HIV transmission between CD4 T cells.

+ cite this

+ View Abstract

Puigdomènech I, Massanella M, Cabrera C, Clotet B, and Blanco J

Retrovirology 6:89, 2009 - Who cited this? | PubMed ID: 19825175 | Fulltext

Opportunistic disease and mortality in patients coinfected with hepatitis B or C virus in the strategic management of antiretroviral therapy (SMART) study.

+ cite this

+ View Abstract

Tedaldi E, Peters L, Neuhaus J, Puoti M, Rockstroh J, Klein MB, Dore GJ, Mocroft A, Soriano V, Clotet B, Lundgren JD, and SMART Study Group and International Network for Strategic Initiatives in Global HIV Trials (INSIGHT)

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 47(11):1468-75, 2008 Dec 1 - Who cited this? | PubMed ID: 18959492 | Fulltext

A randomized, controlled study evaluating an induction treatment strategy in which enfuvirtide was added to an oral, highly active antiretroviral therapy regimen in treatment-experienced patients: the INTENSE study.

+ cite this

+ View Abstract

Clotet B, Capetti A, Soto-Ramirez LE, Gatell JM, Rowell L, Salgo M, and Schapiro JM

The Journal of antimicrobial chemotherapy 62(6):1374-8, 2008 Dec - Who cited this? | PubMed ID: 18782780 | Fulltext

[Lopinavir/ritonavir monotherapy as a simplification strategy in antiretroviral therapy in clinical practice].

+ cite this

+ View Abstract

Moltó J and Clotet B

Enfermedades infecciosas y microbiologia clinica 26 Suppl 16:24-6, 2008 Dec - Who cited this? | PubMed ID: 19572441 | Fulltext

The Magnitude of Interferon-gamma Responses to Human Cytomegalovirus Is Predictive for HIV-1 Disease Progression.

+ cite this

+ View Abstract

Darwich L, Cabrera C, Romeu J, Martinez-Picado J, Esté JA, Tural C, Bellido R, Clotet B, Angulo A, Ruiz L, and Bofill M

Journal of acquired immune deficiency syndromes (1999), 2008 Nov 4 - Who cited this? | PubMed ID: 18989229 | Fulltext

Darunavir inhibitory quotient predicts the 48-week virological response to darunavir-based salvage therapy in human immunodeficiency virus-infected protease inhibitor-experienced patients.

+ cite this

+ View Abstract

Moltó J, Santos JR, Pérez-Alvarez N, Cedeño S, Miranda C, Khoo S, Else L, Llibre JM, Valle M, and Clotet B

Antimicrobial agents and chemotherapy 52(11):3928-32, 2008 Nov - Who cited this? | PubMed ID: 18725446 | Fulltext

Capture and transfer of HIV-1 particles by mature dendritic cells converges with the exosome-dissemination pathway.

+ cite this

+ View Abstract

Izquierdo-Useros N, Naranjo-Gomez M, Archer J, Hatch SC, Erkizia I, Blanco J, Borras FE, Puertas MC, Connor JH, Fernandez-Figueras MT, Moore L, Clotet B, Gummuluru S, and Martinez-Picado J

Blood, 2008 Oct 22 - Who cited this? | PubMed ID: 18945959 | Fulltext

Detection of HIV drug resistance during antiretroviral treatment and clinical progression in a large European cohort study.

+ cite this

+ View Abstract

Cozzi-Lepri A, Phillips AN, Clotet B, Mocroft A, Ruiz L, Kirk O, Lazzarin A, Wiercinska-Drapalo A, Karlsson A, Lundgren JD, and

AIDS (London, England) 22(16):2187-98, 2008 Oct 18 - Who cited this? | PubMed ID: 18832882 | Fulltext

Rational use of antiretroviral therapy in low-income and middle-income countries: optimizing regimen sequencing and switching.

+ cite this

Elliott JH, Lynen L, Calmy A, De Luca A, Shafer RW, Zolfo M, Clotet B, Huffam S, Boucher CA, Cooper DA, and Schapiro JM

AIDS (London, England) 22(16):2053-67, 2008 Oct 18 - Who cited this? | PubMed ID: 18753937 | Fulltext

Cell adhesion through alphaV-containing integrins is required for efficient HIV-1 infection in macrophages.

+ cite this

+ View Abstract

Ballana E, Pauls E, Senserrich J, Clotet B, Perron-Sierra F, Tucker GC, and Este JA

Blood, 2008 Oct 7 - Who cited this? | PubMed ID: 18840709 | Fulltext

Maraviroc for previously treated patients with R5 HIV-1 infection.

+ cite this

+ View Abstract

Gulick RM, Lalezari J, Goodrich J, Clumeck N, DeJesus E, Horban A, Nadler J, Clotet B, Karlsson A, Wohlfeiler M, Montana JB, McHale M, Sullivan J, Ridgway C, Felstead S, Dunne MW,

(show remaining authors)

The New England journal of medicine 359(14):1429-41, 2008 Oct 2 - Who cited this? | PubMed ID: 18832244 | Fulltext

Nadir CD4 Cell Count Predicts Neurocognitive Impairment in HIV-Infected Patients.

+ cite this

+ View Abstract

Muñoz-Moreno JA, Fumaz CR, Ferrer MJ, Prats A, Negredo E, Garolera M, Pérez-Alvarez N, Moltó J, Gómez G, and Clotet B

AIDS research and human retroviruses 24(10):1301-7, 2008 Oct - Who cited this? | PubMed ID: 18844464 | Fulltext

Discovery of novel non-cyclam polynitrogenated CXCR4 coreceptor inhibitors.

+ cite this

+ View Abstract

Pettersson S, Pérez-Nueno VI, Ros-Blanco L, Puig de La Bellacasa R, Rabal MO, Batllori X, Clotet B, Clotet-Codina I, Armand-Ugón M, Esté J, Borrell JI, and Teixidó J

ChemMedChem 3(10):1549-57, 2008 Oct - Who cited this? | PubMed ID: 18671217 | Fulltext

[Introduction].

+ cite this

Clotet B

Enfermedades infecciosas y microbiologia clinica 26 Suppl 10:1-2, 2008 Oct - Who cited this? | PubMed ID: 19195452 | Fulltext

[Pharmacological interactions with darunavir].

+ cite this

+ View Abstract

Moltó J, Valle M, and Clotet B

Enfermedades infecciosas y microbiologia clinica 26 Suppl 10:43-50, 2008 Oct - Who cited this? | PubMed ID: 19195459 | Fulltext

[Position of darunavir in antiretroviral therapy].

+ cite this

Clotet B

Enfermedades infecciosas y microbiologia clinica 26 Suppl 10:61-2, 2008 Oct - Who cited this? | PubMed ID: 19195461 | Fulltext

Secretion of interferon-gamma by human macrophages demonstrated at the single-cell level after costimulation with interleukin (IL)-12 plus IL-18.

+ cite this

+ View Abstract

Darwich L, Coma G, Peña R, Bellido R, Blanco EJ, Este JA, Borras FE, Clotet B, Ruiz L, Rosell A, Andreo F, Parkhouse RM, and Bofill M

Immunology, 2008 Aug 28 - Who cited this? | PubMed ID: 18759749 | Fulltext

Sustained antiretroviral treatment adherence in survivors of the pre-HAART era: attitudes and beliefs.

+ cite this

+ View Abstract

Fumaz CR, Muñoz-Moreno JA, Moltó J, Ferrer MJ, López-Blázquez R, Negredo E, Paredes R, Gómez G, and Clotet B

AIDS care 20(7):796, 2008 Aug - Who cited this? | PubMed ID: 18728987 | Fulltext

Targeting only reverse transcriptase with zidovudine/lamivudine/abacavir plus tenofovir in HIV-1-infected patients with multidrug-resistant virus: a multicentre pilot study.

+ cite this

+ View Abstract

Llibre JM, Bonjoch A, Iribarren J, Galindo MJ, Negredo E, Domingo P, Pérez-Alvarez N, Martinez-Picado J, Schapiro J, Clotet B, and HIV Conference Call Study Group

HIV medicine 9(7):508-13, 2008 Aug - Who cited this? | PubMed ID: 18484978 | Fulltext

Search Google Scholar for Clotet B

Join Labmeeting

Organize and search your PDF collection
Collect papers
Search millions of papers
Keep up to date with paper alerts
Read your papers from anywhere
Recommend papers to colleagues
Manage your lab

Labmeeting is a web service for researchers. Sign up with your academic email address.

Individuals or corporations not affiliated with an academic institution can request a trial subscription.

Papers authored by Clotet B

Join Labmeeting

Sponsored Product